NGDx Scientist

Organization: 
Novartis Institutes for BioMedical Research
Job Location: 
Cambridge, MA
Job Description: 

We are looking for a highly qualified and motivated scientist with in depth experience in next-generation sequencing, technology development, and related bioinformatics analysis.

Responsibilities will include:

Lead a group of scientific associates to design and conduct experiments, to interpret and challenge experimental results and manage the day-to-day tasks of the genomics laboratory

Test and apply new scientific methodologies and techniques to identify and develop innovative solutions to answer experimental / scientific questions

Interact with diverse project teams and provide expertise in genomic technologies and experimental design

Lead development and production efforts for targeted sequencing and other biomarker assays

Conduct library prep, QC, and sequencing work for Illumina instruments

Work closely with bioinformatics colleagues to analyze data and assess data quality

Contribute to the design and implementation of internal data analysis pipelines and LIMS systems

Investigate and evaluate new technologies and make recommendations for implementation

Develop protocols for new technologies and oversee pilot studies

Assist software engineers with the design of informatics around new technologies

Write internal reports and contribute to external publications

Conduct and supervise lab to ensure compliance with Novartis HSE guidelines and policies

Requirements: 

To qualify, candidates must have:

BS/MS in a relevant discipline with at least 5 years of relevant work experience

Hands-on experience with the operation of NGS and associated instrumentation. The ideal candidate will be experienced in various types of NGS data (Exome, RNA-Seq, etc.)

Experience with complementary technologies (e.g. multiplex PCR, qPCR, digital PCR, Nanostring, Raindance, etc)

Familiarity with liquid handling automation, especially with how automation may be used in NGS workflows

Familiarity with lab operations in a quality regulated environment (CLIA, GCLP, GLP, etc) is preferred

Candidates are required to have good organizational and interpersonal skills. Critical thinking skills and the ability to work both independently and collaboratively in a team environment are essential.

Contact Information: 

To learn more and apply, please visit:

http://novartis.avature.net/ngdx/jobDetail?id=416

About Our Organization: 

About Our Organization:

About Novartis Institute for Biomedical Research:
The Novartis Institutes for BioMedical Research is the global pharmaceutical research organization for Novartis. The NIBR research network is comprised of more than 6,000 scientists, physicians, and business professionals working together across 10 locations around the world to discover innovative medicines that treat diseases with high unmet medical need. Novartis employs more than 2,000 associates in Cambridge, making it the city’s largest private employer and ideally situated in one of the leading life science communities in the world.

NIBR conducts research globally with sites in Emeryville, California; Cambridge, MA; East Hanover, NJ; Basel, Switzerland; Horsham, UK; and Shanghai, China.

About the Next Generation Sequencing Group

The ability to sequence each patient’s genome in great detail, quickly and inexpensively, is changing the practice of medicine. At NIBR, we are dedicated to the development of therapies that improve clinical outcomes for patients. Next generation sequencing and other cutting-edge molecular characterization technologies will be important tools for discovering breakthrough therapeutics, and for delivering the right medicines to the right patients.

The NGDx team leverages cutting-edge technologies such as next generation sequencing for characterizing human tissues, by individual lesions and by pathway signatures relevant to therapeutic response. The goal is to develop a robust and comprehensive molecular profile for each patient. To this end, the group will begin by developing capabilities to characterize therapeutically relevant genetic lesions and pathway signatures in human cancer.